
Will Pharma Embrace Open Innovation?
The PharmTech website notes that recent years of low approvals of new blockbuster products have given rise to the perception that pharmaceutical drug development, in its current format, no longer works. Recent late-stage failures of clinical trials have also served to emphasize the risky nature of drug development. So what’s the alternative? Recently,
Comments Off on Will Pharma Embrace Open Innovation? • Read this story »
More Articles

Pharma Industry Continues Building Open Innovation Models
The Nature Biotechnology website reports that seven large pharma companies and a biotech firm, Alnylam, have formed a collaboration with the World Intellectual Property Organisation (WIPO) to establish WIPO Re:Search. This open innovation initiative lines up United Nations agency WIPO of Geneva with